Contribute
España
Italia
대한민국
日本
Français

Benzinga

Research
My Stocks
Tools
Free Benzinga Pro Trial
Updated: Jun 10, 2026

Insider Trades Search

Search Form 4 filings by ticker, company, or insider

PresetsPenny Stock BuysInsider Trading AllInsider Purchases AllInsider Sales AllInsider Purchases Above 25KOfficer Purchases Above 25KCEO/CFO Purchases Above 25KInsider Sales Above 25KOfficer Sales Above 25KCEO/CFO Sales Above 25KInsider Purchases TodayInsider Purchases Past WeekInsider Purchases Past MonthOfficer Purchases TodayOfficer Purchases Past WeekOfficer Purchases Past MonthInsider Sales TodayInsider Sales Past WeekInsider Sales Past MonthOfficer Sales TodayOfficer Sales Past WeekOfficer Sales Past Month
TickerQty.PriceSize ($)Filing DateTypeOwnInsider name & titleTrade DatesScheduledSEC Filing
BHCBausch Health Companies Inc.22.23K$9.40- $209.0KMay, 12 2022Options0.25%
112.74K		Robert Spurrpresident, u.s. businessesMay, 10 - May, 10 2022NoView
BHCBausch Health Companies Inc.-1.59K$22.19- $35.4KApr, 15 2022Sell-0.02%
90.51K		Robert Spurru.s. president pharma businessApr, 14 2022YesView
BHCBausch Health Companies Inc.-4.85K$22.20- $107.6KMar, 16 2022Sell-0.05%
92.10K		Robert Spurru.s. president pharma businessMar, 15 2022YesView
BHCBausch Health Companies Inc.-4.07K$23.61- $96.2KMar, 7 2022Tax-0.04%
96.95K		Robert Spurru.s. president pharma businessMar, 3 2022NoView
BHCBausch Health Companies Inc.165.94K$23.77 $823.8KMar, 4 2022Grant2.48%
232.93K		Robert Spurru.s. president pharma businessMar, 2 - Mar, 2 2022YesView
BHCBausch Health Companies Inc.6.69K$24.35- $597.5KMar, 2 2022Options0.11%
66.99K		Robert Spurru.s. president pharma businessFeb, 26 - Feb, 27 2022NoView
BHCBausch Health Companies Inc.-3.25K$25.02- $81.3KFeb, 17 2022Sell-0.05%
60.30K		Robert Spurru.s. president pharma businessFeb, 15 2022YesView
BHCBausch Health Companies Inc.-3.25K$26.63- $86.6KJan, 20 2022Sell-0.05%
63.55K		Robert Spurru.s. president pharma businessJan, 18 2022YesView
BHCBausch Health Companies Inc.-283.00$28.60- $8.1KOct, 5 2021Tax-0.00%
66.80K		Robert Spurru.s. president pharma businessOct, 1 2021NoView
BHCBausch Health Companies Inc.40.43K——Sep, 3 2021Grant0.70%
98.48K		Robert Spurrpresident, salixSep, 1 - Sep, 1 2021NoView
BHCBausch Health Companies Inc.-1.28K$28.95- $37.0KAug, 31 2021Tax-0.02%
58.06K		Robert Spurrpresident, salixAug, 27 2021NoView
BHCBausch Health Companies Inc.56.64K——Mar, 5 2021Grant1.60%
92.08K		Robert Spurrpresident, salixMar, 3 - Mar, 3 2021NoView
BHCBausch Health Companies Inc.-3.25K$31.42- $102.2KMar, 3 2021Tax-0.08%
35.44K		Robert Spurrpresident, salixMar, 1 2021NoView
BHCBausch Health Companies Inc.-276.00$15.89- $4.4KOct, 6 2020Tax-0.01%
38.70K		Robert Spurrpresident, salixOct, 2 2020NoView
BHCBausch Health Companies Inc.-1.28K$17.00- $21.7KAug, 31 2020Tax-0.03%
38.97K		Robert Spurrpresident, salixAug, 28 2020NoView
BHCBausch Health Companies Inc.———Jun, 1 2020—0.00%
40.25K		Robert Spurrpresident, salix—NoView
RGENREPLIGEN CORP———Mar, 12 2012—0.00%
10.00K		Robert Spurrchief commercial. officer—NoView

Market data provided by Benzinga APIs

Connect With Us
instagramlinkedinyoutubeblueskymastodon
About Benzinga
Market Resources
Trading Tools & Education
Ring the Bell
© 2026 Benzinga | All Rights Reserved